Abstract:Rheumatic heart disease [RHD] is the most prevalent cause of valvular heart disease in the world, outstripping degenerative aortic stenosis numbers fourfold. Despite this, global resources are firmly aimed at improving the management of degenerative disease. Reasons remain complex and include lack of resources, expertise, and overall access to valve interventions in developing nations, where RHD is most prevalent. Is it time to consider less invasive alternatives to conventional valve surgery? Several anatomical and pathological differences exist between degenerative and rheumatic valves, including percutaneous valve landing zones. These are poorly documented and may require dedicated solutions when considering percutaneous intervention. Percutaneous balloon mitral valvuloplasty (PBMV) is the treatment of choice for severe mitral stenosis (MS) but is reserved for patients with suitable valve anatomy without significant mitral regurgitation (MR), the commonest lesion in RHD. Valvuloplasty also rarely offers a durable solution for patients with rheumatic aortic stenosis (AS) or aortic regurgitation (AR). MR and AR pose unique challenges to successful transcatheter valve implantation as landing zone calcification, so central in docking transcatheter aortic valves in degenerative AS, is often lacking. Surgery in young RHD patients requires mechanical prostheses for durability but morbidity and mortality from both thrombotic complications and bleeding on Warfarin remains excessively high. Also, redo surgery rates are high for progression of aortic valve disease in patients with prior mitral valve replacement (MVR). Transcatheter treatments may offer a solution to anticoagulation problems and address reoperation in patients with prior MVR or failing ventricles, but would have to be tailored to the rheumatic environment. The high prevalence of MR and AR, lack of calcification and other unique anatomical challenges remain. Improvements in tissue durability, the development of novel synthetic valve leaflet materials, dedicated delivery systems and docking stations or anchoring systems to securely land the transcatheter devices, would all require attention. We review the epidemiology of RHD and discuss anatomical differences between rheumatic valves and other pathologies with a view to transcatheter solutions. The shortcomings of current RHD management, including current transcatheter treatments, will be discussed and finally we look at future developments in the field.

Rheumatic heart disease manifesting as mitral stenosis and tricuspid regurgitation in a young Asian male: a case report

NEWLY DETECTED SEVERE RHEUMATIC HEART DISEASE IN ELDERLY AND THE CHALLENGES IN ITS MANAGEMENT—A CASE REPORT

Unmasking Rheumatic Heart Disease Decades Later in a Patient With a Remote History of Rheumatic Fever Despite Prolonged Antibiotic Prophylaxis

Echocardiographic Parameters and Complication Profiles Among Adult Patients with Rheumatic Heart Disease at Jimma Medical Center

Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography

Case report: Surgical valvular pulmonary reconstruction for a previous unreported rheumatic right-sided valve disease with severe pulmonary regurgitation

A Hospital-Based Survey of Patients with Severe Valvular Heart Disease in China

Rheumatic heart disease: current status of diagnosis and therapy.

Managing asymptomatic severe rheumatic mitral stenosis in pregnancy: a case report

Isolated rheumatic tricuspid valve regurgitation: it is only rare not just a myth: rare case report

Raising awareness for rheumatic mitral valve disease

Clinical and demographic profile of patients of rheumatic valvular heart disease: A cross-sectional analysis of Varanasi heart valve registry

The first two cases of transcatheter mitral valve repair with ARTO system in Asia.

From Strep Infection to a Strepitous Heart Pattern in Rheumatic Fever: A Case Report

Transcatheter heart valve interventions for patients with rheumatic heart disease

Rheumatic Heart Disease with Multiple Systemic Emboli: A Rare Occurrence in a Single Subject

Transcatheter mitral valve replacement to treat severe calcified rheumatic native mitral stenosis: role of three-dimensional printing-a case report

Spectrum of valvular lesions in newly diagnosed rheumatic heart disease

Transcatheter mitral valve replacement to treat rheumatic mitral stenosis: a case series

Successful Mitral Valve Replacement in a 13-Year-Old With Active Carditis and Acute Severe Mitral Regurgitation

Open Heart Dual Valve Surgery Without Blood Transfusion: A Case Report